Search Results 671-680 of 14739 for anti-TNF drugs

1. Diphtheria, Tetanus, And Acellular Pertussis Booster Vaccine (Intramuscular Route) Side Effects - Mayo Clinic

   Side Effects. Drug information provided by: Merative, Micromedex®. Along with its needed effects, a medicine may cause some unwanted effects. Although not ...

2. Butalbital, Acetaminophen, Caffeine, And Codeine (Oral Route) Description and Brand Names - Mayo Clinic

   It has also been used for migraine headaches. Codeine belongs to the group of medicine called narcotic analgesics (pain medicines). It acts on the central ...

3. Neomycin, Polymyxin B, And Hydrocortisone (Otic Route) Description and Brand Names - Mayo Clinic

   Neomycin and polymyxin B belong to the class of medicines known as antibiotics. They work by killing the bacteria or preventing their growth.

4. A Study to Test the Addition of the Immunotherapy Drug Pembrolizumab to the Usual Chemotherapy Treatment (Paclitaxel and Carboplatin) in Stage III-IV or Recurrent Endometrial Cancer - Mayo Clinic

   This study aims to assess if adding immunotherapy to these drugs is better or worse than the usual approach for treatment of this cancer. Participation ...

5. CAR-T Cell Therapy Program - Frequently asked questions - Mayo Clinic

   Mantle cell lymphoma; Follicular lymphoma; Multiple myeloma. How do I know if I'm eligible for CAR-T cell therapy at Mayo Clinic? In ...

6. Some Pain Drugs Increase the Risk of Heart Attack - Mayo Clinic News Network

   The April issue of Mayo Clinic Health Letter covers the risks of nonsteroidal anti-inflammatory drugs (NSAIDs) that include celecoxib (Celebrex), diclofenac ( ...

7. Peginterferon Alfa-2b (Subcutaneous Route) Precautions - Mayo Clinic

   Using PegIntron® alone or together with ribavirin while you are pregnant can harm your unborn baby. These medicines may also cause birth defects if the ...

8. A Randomized Phase 2 Study of Combination Atezolizumab and CDX-1127 (Varlilumab) With or Without Addition of Cobimetinib in Previously Treated Unresectable Biliary Tract Cancers - Mayo Clinic

   methotrexate, thalidomide, and anti-tumor necrosis factor [anti-TNF] agents) within 2 weeks prior to randomization. - Patients who have received acute, low ...

9. Urology Clinical Trials - Medical Professionals

   Clinical Trials · A Study to Test the Effectiveness of Two Immunotherapy Drugs (Nivolumab and Ipilimumab) with One Anti-cancer Targeted Drug (Cabozantinib) for ...

10. Nivolumab (Intravenous Route) Description and Brand Names - Mayo Clinic

    Nivolumab injection is also used with chemo medicines containing platinum before having surgery for non-small cell lung cancer (NSCLC).